Literature DB >> 2949017

IgE receptor-mediated depolarization of rat basophilic leukemia cells measured with the fluorescent probe bis-oxonol.

F C Mohr, C Fewtrell.   

Abstract

Receptor-mediated changes in plasma membrane potential were recorded in rat basophilic leukemia (RBL) cells with the potential-sensitive fluorescent indicator bis-oxonol. Depolarization of the mitochondria with metabolic inhibitors was not detected by bis-oxonol, suggesting that only potential changes across the plasma membrane were being measured. The resting membrane potential of RBL cells was largely generated by the equilibrium distribution of K+ and not through electrogenic activity of the sodium pump. Depolarization was maintained as long as IgE receptors remained aggregated. We believe that at physiologic calcium concentrations a large portion of the measured potential change may be due to calcium influx across the plasma membrane. Prevention of calcium influx by lanthanum, disruption of aggregated receptors, or prior depolarization in a high K+ saline solution completely inhibited the antigen-induced depolarization. The time course of the antigen-stimulated increase in bis-oxonol fluorescence was similar, but not identical, to the antigen-stimulated rise in cytoplasmic free ionized calcium measured with fura-2. Antigen-stimulated depolarization was inhibited by removing both calcium and sodium and could be restored by the addition of either ion. Reduction of total cellular adenosine triphosphate inhibited depolarization in response to antigen stimulation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2949017

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Na(+)-dependent Ca(2+) transport modulates the secretory response to the Fcepsilon receptor stimulus of mast cells.

Authors:  E Rumpel; U Pilatus; A Mayer; I Pecht
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

2.  Characterization of whole-cell currents in mucosal and connective tissue rat mast cells using amphotericin-B-perforated patches and temperature control.

Authors:  P B Hill; R J Martin; H R Miller
Journal:  Pflugers Arch       Date:  1996-10       Impact factor: 3.657

3.  Kinetic study of the plasma-membrane potential in procyclic and bloodstream forms of Trypanosoma brucei brucei using the fluorescent probe bisoxonol.

Authors:  F Defrise-Quertain; C Fraser-L'Hostis; D Coral; J Deshusses
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

Review 4.  Regulation of Ca2+ signaling with particular focus on mast cells.

Authors:  Hong-Tao Ma; Michael A Beaven
Journal:  Crit Rev Immunol       Date:  2009       Impact factor: 2.214

5.  Activation of mast cell K+ channels through multiple G protein-linked receptors.

Authors:  Y X Qian; M A McCloskey
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

6.  Ceramide inhibits inwardly rectifying K+ currents via a Ras- and Raf-1-dependent pathway in cultured oligodendrocytes.

Authors:  H Hida; M Takeda; B Soliven
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

7.  Membrane potential modulates release of tumor necrosis factor in lipopolysaccharide-stimulated mouse macrophages.

Authors:  A Haslberger; C Romanin; R Koerber
Journal:  Mol Biol Cell       Date:  1992-04       Impact factor: 4.138

8.  Immunologically activated chloride channels involved in degranulation of rat mucosal mast cells.

Authors:  C Romanin; M Reinsprecht; I Pecht; H Schindler
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

9.  G protein control of potassium channel activity in a mast cell line.

Authors:  M A McCloskey; M D Cahalan
Journal:  J Gen Physiol       Date:  1990-02       Impact factor: 4.086

10.  Heterogeneity of lymphocyte calcium metabolism is caused by T cell-specific calcium-sensitive potassium channel and sensitivity of the calcium ATPase pump to membrane potential.

Authors:  Y Ishida; T M Chused
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.